CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Zaks Tal Zvi Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | Crane Rosemary A Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | Satchi-Fainaro Ronit Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | MIGNONE ROBERTO Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | Nisen Perry Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | LIEBERMAN GERALD M Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | Vergis Janet S. Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | Elstein Amir Director | Grant or award · Restricted Share Units | +9,632 | 9,632 | ||
| 2024-06-06 | BARER SOL J Director | Grant or award · Restricted Share Units | +17,158 | 17,158 | ||
| 2024-06-03 | Shields Matthew EVP, Global Operations | Grant or award · Restricted Share Units | +64,782 | 64,782 | ||
| 2024-05-16 | Weiss Amir Chief Accounting Officer | Sale | −12,635 | $16.65 | $210K | 5,179 |
| 2024-05-15 | Weiss Amir Chief Accounting Officer | Sale | −15,500 | $16.80 | $260K | 17,814 |
| 2024-05-13 | Conway Vikki L See "Remarks" | Sale | −15,219 | $16.74 | $255K | 0 |
| 2024-03-06 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale 10b5-1 | −77,550 | $13.52 | $1.0M | 203,691 |
| 2024-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise 10b5-1 | +52,320 | 259,854 | ||
| 2024-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise 10b5-1 | +21,387 | 281,241 | ||
| 2024-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units 10b5-1 | −21,387 | 21,390 | ||
| 2024-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units 10b5-1 | −52,320 | 0 | ||
| 2024-03-05 | Drape Eric Executive VP Global Operations | Option exercise 10b5-1 | +22,576 | 90,689 | ||
| 2024-03-05 | Drape Eric Executive VP Global Operations | Option exercise 10b5-1 | +55,226 | 145,915 |
Page 21 of 76 · 1,517 trades